244 related articles for article (PubMed ID: 19900676)
1. Toll like receptor 4 in atherosclerosis and plaque destabilization.
den Dekker WK; Cheng C; Pasterkamp G; Duckers HJ
Atherosclerosis; 2010 Apr; 209(2):314-20. PubMed ID: 19900676
[TBL] [Abstract][Full Text] [Related]
2. STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease.
Sikorski K; Czerwoniec A; Bujnicki JM; Wesoly J; Bluyssen HA
Cytokine Growth Factor Rev; 2011 Aug; 22(4):211-9. PubMed ID: 21752694
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 4 mediates oxidized LDL-induced macrophage differentiation to foam cells.
Howell KW; Meng X; Fullerton DA; Jin C; Reece TB; Cleveland JC
J Surg Res; 2011 Nov; 171(1):e27-31. PubMed ID: 21920554
[TBL] [Abstract][Full Text] [Related]
4. Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness.
Schoneveld AH; Hoefer I; Sluijter JP; Laman JD; de Kleijn DP; Pasterkamp G
Atherosclerosis; 2008 Mar; 197(1):95-104. PubMed ID: 17888930
[TBL] [Abstract][Full Text] [Related]
5. Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque.
Niessner A; Shin MS; Pryshchep O; Goronzy JJ; Chaikof EL; Weyand CM
Circulation; 2007 Oct; 116(18):2043-52. PubMed ID: 17938289
[TBL] [Abstract][Full Text] [Related]
6. Multiple roles of Toll-like receptor signaling in atherosclerosis.
Björkbacka H
Curr Opin Lipidol; 2006 Oct; 17(5):527-33. PubMed ID: 16960501
[TBL] [Abstract][Full Text] [Related]
7. Expansion of circulating Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome.
Methe H; Kim JO; Kofler S; Weis M; Nabauer M; Koglin J
Circulation; 2005 May; 111(20):2654-61. PubMed ID: 15883205
[TBL] [Abstract][Full Text] [Related]
8. Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease.
Pasterkamp G; Van Keulen JK; De Kleijn DP
Eur J Clin Invest; 2004 May; 34(5):328-34. PubMed ID: 15147329
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 4 in atherosclerosis.
Li H; Sun B
J Cell Mol Med; 2007; 11(1):88-95. PubMed ID: 17367503
[TBL] [Abstract][Full Text] [Related]
10. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036
[TBL] [Abstract][Full Text] [Related]
11. Innate immune system cells in atherosclerosis.
Chávez-Sánchez L; Espinosa-Luna JE; Chávez-Rueda K; Legorreta-Haquet MV; Montoya-Díaz E; Blanco-Favela F
Arch Med Res; 2014 Jan; 45(1):1-14. PubMed ID: 24326322
[TBL] [Abstract][Full Text] [Related]
12. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.
Koulis C; Chen YC; Hausding C; Ahrens I; Kyaw TS; Tay C; Allen T; Jandeleit-Dahm K; Sweet MJ; Akira S; Bobik A; Peter K; Agrotis A
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):516-25. PubMed ID: 24436372
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor signaling pathways in cardiovascular diseases: challenges and opportunities.
Moghimpour Bijani F; Vallejo JG; Rezaei N
Int Rev Immunol; 2012 Oct; 31(5):379-95. PubMed ID: 23083347
[TBL] [Abstract][Full Text] [Related]
14. Mast cells induce vascular smooth muscle cell apoptosis via a toll-like receptor 4 activation pathway.
den Dekker WK; Tempel D; Bot I; Biessen EA; Joosten LA; Netea MG; van der Meer JW; Cheng C; Duckers HJ
Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):1960-9. PubMed ID: 22652603
[TBL] [Abstract][Full Text] [Related]
15. Innate immune signals in atherosclerosis.
Lundberg AM; Hansson GK
Clin Immunol; 2010 Jan; 134(1):5-24. PubMed ID: 19740706
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of innate immune cells: impact on atherosclerosis.
Riksen NP; Stienstra R
Curr Opin Lipidol; 2018 Oct; 29(5):359-367. PubMed ID: 30020200
[TBL] [Abstract][Full Text] [Related]
17. Regulation of innate immune responses by Toll-like receptors.
Takeda K; Akira S
Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
[TBL] [Abstract][Full Text] [Related]
18. The forward genetic dissection of afferent innate immunity.
Beutler B; Moresco EM
Curr Top Microbiol Immunol; 2008; 321():3-26. PubMed ID: 18727485
[TBL] [Abstract][Full Text] [Related]
19. The lack of association between four point mutations in the promoter region of the toll-like 4 receptor gene and myocardial infarction.
De Staercke C; Lally C; Austin H; Winston C; Dowling N; Williams B; Hooper WC
Thromb Res; 2007; 119(1):105-10. PubMed ID: 16469362
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of TLR4 signaling pathway: molecular treatment strategy of periodontitis-associated atherosclerosis.
Huang B; Chen H; Fan M
Med Hypotheses; 2008; 70(3):614-7. PubMed ID: 17681703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
